Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Preparation of a Mouse Anti-Human DC-SIGN Monoclonal Antibody and Identification on the Expression of the DC-SIGN Molecules

Preparation and characterization of a novel monoclonal antibody against human PD-1

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

Microsoft Word-Yuan et al PDF

New monoclonal anti-mouse DC-SIGN antibodies reactive with acetone-fixed cells

Selection of DNA Aptamers Against DC-SIGN Protein

[Preparation and Characterization of a Novel Functional Anti-Human CD83 Monoclonal Antibody].

[Preparation and Characterization of a Directly Labeled Mouse Anti-Human CD14 Monoclonal Antibody ZCH-2F9-FITC].

[Preparation of Two Mouse Anti-Human PD-1 Monoclonal Antibodies and Identification of Their Biological Characteristics].

[Preparation and Characterization of a Mouse Anti-Human CD40 Mutant Monoclonal Antibody].

Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.

Cloning and Expression of Human DC-SIGN, Purification and Identification of the Recombinant Protein

Preparation and Characterization of a Novel Monoclonal Antibody Against Human PD-L2 (B7-DC)

Preparation of Functional Anti-Human Syndecan-1 Monoclonal Antibody and Its Biological Characteristics

Cloning of Human DC-SIGN Gene and Construction of Its Transgenic Cells

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Preparation of a Novel Functional Mouse Anti-Human 2Igb7-H3 Antibody and Primary Study of Its Biological Characteristics.

Preparation,characterization,and Application of Monoclonal Antibodies Against Human Decoy Receptor 3

A Monoclonal Antibody to the DEC-205 Endocytosis Receptor on Human Dendritic Cells.

Construction and Expression of a Human/mouse Chimeric CD19 Monoclonal Antibody: Successful Modification of a Murine IgM to a Chimeric IgG.

[Preparation of a Novel Functional Anti-Human CD40 Monoclonal Antibody and Identification of Its Bioactivity].